The U.S. Food and Drug Administration (FDA) issued a nationwide recall last week of thousands of bottles of blood pressure medication after detecting cross-contamination with a different drug.
Federal regulators issued the warning on Dec. 1 for about 11,100 bottles of the combination drug bisoprolol fumarate and hydrochlorothiazide, sold as Ziac.
Testing found “trace amounts of ezetimibe,” a cholesterol-lowering medication, in reserve samples. The recall was designated Class III, meaning use or exposure is “not likely to cause adverse health consequences,” according to the agency.
Glenmark Pharmaceuticals, based in Elmwood Park, New Jersey, manufactures both the recalled blood-pressure tablets and ezetimibe. The affected pills were distributed in 2.5-milligram and 6.25-milligram doses.
The FDA added that the recall affects 30-count bottles (NDC 68462-878-30), 100-count bottles (NDC 68462-878-01), and 500-count bottles (NDC 68462-878-05). The recalled lot numbers carry expiration dates ranging from November 2025 to May 2026.
